pharma news today glp-1 Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating History of GLP-1 Medications -

Supports healthier skin by reducing inflammation and promoting collagen production

The September 2024 LIFT-AD trial termination after meeting enrollment demonstrates that this approach, despite decades of development, does not slow Alzheimer's cognitive decline in humans

Patients with certain liver or kidney conditions may not be ideal candidates (because glutathione is involved in detoxification/clearance) Cautions for a Pill Generally a safer option, but some may experience digestive upset, bloating, or decreased efficacy due to absorption

Wanner C, Horl WH: Carnitine abnormalities in patients with renal insufficiency

These products do not contain real prescription GLP-1 medications like semaglutide or tirzepatide

The combination eliminates the need for two separate injections, reduces total injection volume, and ensures consistent dosing ratios optimized for synergistic effects